All filters
Slidesets
Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. Hack
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
New Designs for Early Clinical Trials of IO Drugs - Emiliano Calvo, Md, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Changes and Challenges in Early Phase Trial Endpoints - Ruth Plummer, MD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Long Term Pemetrexed-based Cancer Treatment Leads to Nephrotoxicity - Nikki de Rouw
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Prediction of Capecitabine induced Severe Toxicity using Machine Learning Techniques - Maël Steunou
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
The Long and Winding Road of the Clinical Introduction of a Biomarker - Jack Schalken, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
The Use of Radiolabeled and Fluorescent Monoclonal Antibodies for Molecular Imaging in Oncology - Annelies Jorritsma-Smit, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Epigenetic Regulation of OCTN1-mediated Cytarabine Transport in Acute Myeloid Leukemia - Jason Anderson
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
How System Pharmacology Can Facilitate Clinical Drug Development in Oncology - Piet van der Graaf, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Impact of Immortal Time and Selection Bias on Exposure-response Modelling - Mats Karlsson, PhD, FCP, FISoP
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Challenges in the Development of Immunotherapy - Candice Jamois, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Optimal Study Design of Oncology Trials - Patricia LoRusso, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le Louedec
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van Eerden
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019